Filing Details
- Accession Number:
- 0001140361-16-056820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-07 17:15:17
- Reporting Period:
- 2016-03-03
- Filing Date:
- 2016-03-07
- Accepted Time:
- 2016-03-07 17:15:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641489 | Vtv Therapeutics Inc. | VTVT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275756 | G Paul Savas | C/O Vtv Therapeutics Inc. 4170 Mendenhall Oaks Pkwy High Point NC 27265 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2016-03-03 | 10,000 | $5.86 | 30,000 | No | 4 | P | Direct | |
| Class A Common Stock | Acquisiton | 2016-03-07 | 6,522 | $0.00 | 36,522 | No | 4 | C | Direct | |
| Class A Common Stock | Acquisiton | 2016-03-07 | 5,000 | $5.74 | 41,522 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Nonvoting Common Units and Class B common stock | Disposition | 2016-03-07 | 6,522 | $0.00 | 6,522 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.63 to $5.90, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnotes 1 and 3 to this Form 4.
- Pursuant to the terms of the Exchange Agreement, dated as of July 29, 2015 (the "Exchange Agreement"), by and among the Issuer, vTv Therapeutics LLC and M&F TTP Holdings LLC, as successor-in-interest to vTv Therapeutics Holdings LLC ("Holdings"), Nonvoting Common Units of vTv Therapeutics LLC ("vTv Units"), together with a corresponding number of shares of Class B common stock of the Issuer ("Class B Common Stock"), may be exchanged for (i) Class A common stock of the Issuer ("Class A Common Stock"), which have one vote per share and represent economic interests, on a one-for-one basis or (ii) cash (based on the market price of the shares of Class A Common Stock), at the option of the Issuer. The exchange rights under the Exchange Agreement do not expire.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.61 to $5.85, inclusive.
- Shares of Class B Common Stock have one vote per share but represent no economic interests and are issued in an equal amount to the number of vTv Units held.
Billionaire Hedge Funds
